10 For 10: Top Compliance Stories For the Week Ending August 23, 2025
AI Today in 5: August 22, 2025, The Angst Episode
Compliance into the Weeds: The Dark Side of AI in Employee Training
Compliance Tip of the Day: AI Assistant for Compliance
Compliance Tip of the Day: Co-Thinking with AI
Compliance Tip of the Day: AI, Continuous Monitoring and Compliance
Money-Saving Licensing Tips for Startups
Just Press "Play"
Lawyers Beware: There Could Be Serious Ethics Issues With The New AI Browsers
Project Catalyst an Economic Development Video Podcast | Episode 16: Powering Alabama’s Economic Progress with Leigh Davis of Alabama Power Company
LathamTECH in Focus: Navigating National Security: The Impact of FDI Reviews on Tech M&A
Podcast - Ejecución de facturas electrónicas
The Privacy Insider Podcast Episode 16: Protecting Privacy at Every Walk of Life with France Bélanger and Donna Wertalik of Virginia Tech
Julie Mortimer of Mills & Reeve on The Right Way to Kickstart Your CRM Strategy - Passle's CMO Series Podcast EP176
Sunday Book Review: July 20, 2025, The Best Books on Business Edition
Hospice Insights Podcast - AI in Action: Exploring How AI Is Helping Hospices Do Things in New Ways
Empowerment Through Hero Generation with Nicole a`Beckett and Dr. Shruti Roy
How to Rank in the Age of AI Search: On Record PR
SBR-Authors Podcast: A Journey Through Memoir, Technology, and Grief with Tony Stewart
Episode 373 -- Christian Focacci on Current Developments in AI and Risk Management
The US Food and Drug Administration (FDA) launched Elsa, a generative artificial intelligence (AI) tool designed to assist FDA employees with tasks such as reading, writing, and summarizing. The press release on the tool’s...more
During this session, the panelists discussed the role that SMOs and dedicated clinical trial sites (Site Platforms) play within the life sciences industry, what makes them attractive to investors, and the key criteria...more
The food, drug and medical device industries comprise some of the most closely regulated sectors in the United States. The US Food & Drug Administration (FDA) actively exercises authority by constantly changing legislation...more
Jones Day partner Maureen Bennett talks about how advancements in digital technology and their clinical trial applications have introduced additional regulatory regimes in the United States and the European Union, and...more
On January 27, 2015, members of the House Commerce and Energy Committee unveiled a set of legislative proposals aimed at speeding up the development of new medical technology. The 21st Century Cures panel, a bipartisan...more
The FDA issued a new draft guidance on July 15th which further explains how the FDA currently fails to protect consumers of medical devices and pharmaceutical drugs. It is important to remember that these sort of FDA-issued...more